What is Molekule Group, Inc. (MKUL)?

Molekule Group, Inc. (MKUL) is a stock in the Industrials sector, Industrial - Pollution & Treatment Controls industry. View full analysis on Stocks360.

What is the current price of MKUL?

The current price of MKUL is $0.05. Prices are updated in real time on Stocks360.

What is MKUL's price-to-earnings (PE) ratio?

MKUL's trailing twelve-month PE ratio is -0.54, based on current price and earnings per share data available on Stocks360.

What is MKUL's market capitalization?

MKUL's market capitalization is $1,874,808.00, placing it in the small-cap tier.

Molekule Group, Inc. (MKUL)

Stock analysis · NASDAQ · Industrials · Industrial - Pollution & Treatment Controls

$0.05

Market Cap

$1.87M

PE (TTM)

-0.54

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

12.53

Day Range

$0.05 – $0.09

52-wk Range

$0.02 – $4.23

Avg Volume

N/A

Volume

7.88M

Molekule Group, Inc. (MKUL) is a publicly traded company in the Industrials sector. Latest price: $0.05. Market cap $1.87M. Trailing PE -0.54. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent

Aug 14, 2023

EPS $-0.30 vs est. $-0.24

Missed by $0.06

Proprietary Signals

Signal snapshot temporarily unavailable.

About Molekule Group, Inc.

Molekule Group, Inc., founded in 2011 and based in Palm Beach Gardens, Florida, is a technology company specializing in advanced air purification systems for interior spaces. Previously operating as AeroClean Technologies, Inc. until its rebranding in January 2023, the company's primary mission is to provide air sterilization and disinfection solutions capable of eradicating dangerous airborne pathogens, including COVID-19, particularly within hospitals and other healthcare settings. A key product in their portfolio is Purgo (pronounced pure-go), a certified medical device that delivers continuous air filtration, sanitization, and supplemental ventilation. This innovative system, which incorporates their patented SteriDuct germicidal technology, is versatile enough for deployment in diverse indoor environments such as hospitals, corporate offices, and even elevators, aiming to minimize occupants' exposure to airborne particles and harmful pathogens. Molekule Group also offers a range of air purifiers designed for broader consumer and business markets. The Air Mini+, a direct-to-consumer model, includes a particle sensor, five distinct fan speeds, and an 'auto protect' mode for aut…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.54×
P/S (TTM)	0.04×
P/B	-0.03×
PEG	0.01×
P/FCF (TTM)	-0.04×
EV / EBITDA	3.71×
EV / Sales	0.96×
Earnings Yield	-185.15%
Free Cash Flow Yield	-2350.33%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$46.22M
Revenue (TTM)	$48.03M
Net Income (TTM)	-$3.47M
Free Cash Flow (TTM)	-$39.95M
Net Debt	$44.34M
Working Capital	$10.60M
Gross Margin	32.38%
Operating Margin	-68.26%
Net Margin	-3.23%
Return on Equity	56.41%
Return on Invested Capital	-89.94%